| 呼吸器・乳腺外科学 | |||||||
| Thoracic and Breast Surgery | |||||||
| 整理番号 | 論文の種類 | 著者名 | 論文タイトル | 誌名・書名等 | 巻号ページ | 年 | doi |
| 2146001 | 原著 | Sakai K,
Tsuboi M, Kenmotsu H, Yamanaka T, Takahashi T, Goto K, Daga H, Ohira T, Ueno
T, Aoki T, Nakagawa K, Yamazaki K, Hosomi Y, Kawaguchi K, Okumura N, Takiguchi Y, Sekine A, Haruki T, Yamamoto H, Sato Y, Akamatsu H, Seto T, Saeki S, Sugio K, Nishio M, Okabe K, Yamamoto N, Nishio K. |
Tumor mutation burden as a biomarker for lung cancer patients treated with pemetrexed and cisplatin (the JIPANG-TR). | Cancer Sci | 112(1):388-396. | 2021 | 10.1111/cas.14730 |
| 2146002 | 原著 | Asahina H, Tanaka K, Morita S, Maemondo M, Seike M, Okamoto I,
Oizumi S, Kagamu H, Takahashi K, Kikuchi T, Isobe T, Sugio K, Kobayashi K. |
A Phase II Study of Osimertinib Combined With Platinum Plus Pemetrexed in Patients With EGFR-Mutated Advanced Non–Small-cell Lung Cancer: The OPAL Study (NEJ032C/LOGIK1801). | Clin Lung Cancer | 22(2)147-151. | 2021 | 10.1016/j.cllc.2020.09.023 |
| 2146003 | 原著 | Tsuchiya T, Matsumoto K, Miyazaki T, Doi R, Tokunaga S,
Yamaguchi H, Tomoshige K, Watanabe H, Nagayasu T, Sugio K. |
A randomized phase II study of S-1 monotherapy versus cisplatin with vinorelbine for completely resected stage II/IIIA non-small cell lung cancer: rationale and study protocol design for the LOGIK1702 study. | BMC Cancer | 21(1):249. | 2021 | 10.1186/s12885-021-07945-y |
| 2146004 | 原著 | Tanaka K, Asahina H, Kishimoto J, Miyata Y, Uchida T, Watanabe K, Hamai K, Harada T, Tsubata Y, Sugawara S, Kobayashi K, Sugio K, Oizumi S, Okamoto I. | Osimertinib versus osimertinib plus chemotherapy for non-small cell lung cancer with EGFR (T790M)-associated resistance to initial EGFR inhibitor treatment: An open-label, randomised phase 2 clinical trial. | Eur J Cancer | 149:14-22. | 2021 | 10.1016/j.ejca.2021.02.019 |
| 2146005 | 原著 | Osoegawa A, Yamaguchi M, Nakamura T, Morinaga R, Tanaka K, Kashiwabara K, Miura T, Suetsugu T, Harada T, Asoh T, Taguchi K, Nabeshima K, Kishimoto J, Sakai K, Nishio K, Sugio K. |
High Incidence of C797S Mutation in Patients With Long Treatment History of EGFR Tyrosine Kinase Inhibitors Including Osimertinib. | JTO Clin Res Rep | 2(7):100191. | 2021 | 10.1016/j.jtocrr.2021.100191 |
| 2146006 | 原著 | Hotta K, Saeki S, Yamaguchi M, Harada D, Bessho A, Tanaka K,
Inoue K, Gemba K, Shiojiri M, Kato Y, Ninomiya T, Kubo T, Kishimoto J, Shioyama Y, Katsui K, Sasaki J, Kiura K, Sugio K. |
Gefitinib induction followed by chemoradiotherapy in EGFR-mutant, locally advanced non-small-cell lung cancer: LOGIK0902/OLCSG0905 phase II study. | ESMO Open | 6(4):100191. | 2021 | 10.1016/j.esmoop.2021.100191 |
| 2146007 | 原著 | Abe M, Miura M, Hamada F, Sugio K. | Arterial blood supply patterning of the mammary sentinel
lymph nodes with special reference to the relation of the formation mechanism of the superfcial subscapular artery. |
Anat Sci Int | 96(4):489-508. | 2021 | 10.1007/s12565-021-00616-9 |
| 2146008 | 原著 | Yamaguchi H, Wakuda K, Fukuda M, Kenmotsu H, Mukae H, Chibana K,
Inoue K, Miura S, Tanaka K, Ebi N, Suetsugu T, Harada T, Kirita K, Yokoyama
T, Nakatani Y, Yoshimura K, Nakagawa K, Yamamoto N, Sugio K. |
A Phase II Study of Osimertinib for Radiotherapy-Naive Central Nervous System Metastasis From NSCLC: Results for the T790M Cohort of the OCEAN Study (LOGIK1603/WJOG9116L). | J Thorac Oncol | 16(12):2121-2132 | 2021 | 10.1016/j.jtho.2021.07.026 |
| 2146009 | 原著 | Sugio K, Okamoto T, Maniwa Y, Toh Y, Okada M, Yamashita T, Shinohara S, Yoshino I, Chida M, Kuwano H, Shiotani A. |
Descending necrotizing mediastinitis and the proposal of a new classification. | JTCVS Open | 8(Number C):633-347. | 2021 | doi.org/10.1016/j.xjon.2021.08.001 |
| 2146010 | 症例報告 | Noda D, Abe M, Takumi Y, Anami K, Miyawaki M, Takeuchi H, Osoegawa A, Sugio K. | Resection and postoperative radiation therapy for desmoid fibromatosis of the chest wall in a young woman. | Surg Case Rep | 7(1):28. | 2021 | 10.1186/s40792-020-01006-5 |
| 2146011 | 症例報告 | Miyawaki M, Jikumaru M, Kamada K, Daiki N, Abe M, Anami K, Takeuchi H, Osoegawa A, Iwao S, Matsubara E, Sugio K. | Thymoma-associated myasthenia gravis coexisting with myotonic
dystrophy: a case report. |
Surg Case Rep | 7(1):159. | 2021 | 10.1186/s40792-021-01223-6 |
| 2146012 | 総説 | 宮脇美千代, 小副川敦, 杉尾賢二. | 肺・胸腺神経内分泌腫瘍の治療，6.小細胞癌の治療. | 日本外科学会雑誌 | 122(1):1-5. | 2021 | |
| 2146013 | Proceedings | Tada H, Mitsudomi T, Ymanaka T, Sugio K, Tsuboi M, Okamoto I,
Iwamoto Y, Sakakura N, Sugawara S, Atagi S, Takahashi T, Hayashi H, Okada M,
Yoshioka H, Inokawa H, Takahashi K, Hayashiyama M, Yoshino I, Nakagawa K, West Japan Oncology Group. |
Adjuvant gefitinib versus cisplatin/vinorelbine in Japanese patients with completely resected, EGFR-mutated, stage II-III non-small cell lung cancer (IMPACT, WJOG6410L): A randomized phase 3 trial. | ASCO Annual Meeting 2021 | Abstract Session Lung Cancer—Non-Small Cell LocalRegional/Small
Cell/Other Thoracic Cancers 8:00 AM – 11:00 AM |
2021 | |